GlassScriptPhysician profile
Joshua Russell
NPI 1407297039
$45,761.82
in general payments reported to CMS, 2019-2025
16 companies · $164 in 2025
The $164 reported for 2025 was less than what a typical Sports Medicine (Orthopaedic Surgery) provider received nationally (typical 2025 total: $686).
See the full distribution for Sports Medicine (Orthopaedic Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $25K · 2020: $6,999 · 2021: $8,336 · 2022: $4,774 · 2023: $250 · 2024: $437 · 2025: $164.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $851.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $851.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $26,037.52 | 2019-2024 | Arthrex |
| Pylant Medical | $13,019.07 | 2020-2025 | |
| Medinc of Texas | $3,718.19 | 2019-2025 | |
| Stryker Corporation | $2,246.55 | 2020-2023 | Mako |
| Smith+Nephew, INC. | $190.78 | 2020-2022 | |
| Pacira Pharmaceuticals Incorporated | $111.24 | 2020 | |
| Medacta USA, INC. | $90.37 | 2022 | |
| Zimmer Biomet Holdings, INC. | $70.96 | 2025 | Persona |
| Bioventus LLC | $66.24 | 2021-2024 | Durolane, Durolane |
| Vertex Pharmaceuticals Incorporated | $39.82 | 2025 | |
| Ferring Pharmaceuticals INC. | $37.74 | 2020 | |
| Alafair Biosciences, INC. | $35.67 | 2022 | |
| Medical Device Business Services, INC. | $31.44 | 2023 | Inhance |
| Depuy Synthes Sales INC. | $30.93 | 2024 | Monovisc, Orthovisc |
| Vericel Corporation | $21.94 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kowa Pharmaceuticals America, INC. | $13.36 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joshua Russell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.